Behavioral and neuropsychiatric challenges across the lifespan in individuals with Rubinstein-Taybi syndrome
暂无分享,去创建一个
L. Schmitt | A. Slavotinek | I. Riddle | Diana S Brightman | Dima Qu’d | J. Harris | Brittany N. Simpson | Amber Leston | Jacqueline R. Harris
[1] L. Schmitt,et al. Systematic Review: Emotion Dysregulation in Syndromic Causes of Intellectual and Developmental Disabilities. , 2022, Journal of the American Academy of Child and Adolescent Psychiatry.
[2] G. Michelini,et al. Age-related hallmarks of psychopathology in Cornelia de Lange and Rubinstein-Taybi syndromes. , 2022, Research in developmental disabilities.
[3] R. Hennekam,et al. The natural history of adults with Rubinstein-Taybi syndrome: a families-reported experience , 2022, European Journal of Human Genetics.
[4] C. Barthélémy,et al. A comparative study of cognitive and socio-emotional development in children with Rubinstein-Taybi syndrome and children with Autism Spectrum Disorder associated with a severe intellectual disability, and in young typically developing children with matched developmental ages. , 2021, Research in developmental disabilities.
[5] L. Lynd,et al. Out‐of‐pocket and private pay in clinical genetic testing: A scoping review , 2021, Clinical genetics.
[6] E. Zackai,et al. EP300‐related Rubinstein–Taybi syndrome: Highlighted rare phenotypic findings and a genotype–phenotype meta‐analysis of 74 patients , 2020, American journal of medical genetics. Part A.
[7] V. Faundes,et al. FMR1 mRNA from full mutation alleles is associated with ABC-CFX scores in males with fragile X syndrome , 2020, Scientific Reports.
[8] I. Apperly,et al. An Observational Study of Social Interaction Skills and Behaviors in Cornelia de Lange, Fragile X and Rubinstein-Taybi Syndromes , 2020, Journal of autism and developmental disorders.
[9] Z. Al-Hassnan,et al. Rubinstein-Taybi syndrome in a Saudi boy with distinct features and variants in both the CREBBP and EP300 genes: a case report , 2019, BMC Medical Genetics.
[10] S. Avignone,et al. Rubinstein–Taybi syndrome: New neuroradiological and neuropsychiatric insights from a multidisciplinary approach , 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[11] C. Oliver,et al. Diverse Profiles of Anxiety Related Disorders in Fragile X, Cornelia de Lange and Rubinstein–Taybi Syndromes , 2017, Journal of autism and developmental disorders.
[12] B. D. de Vries,et al. Phenotype and genotype in 52 patients with Rubinstein–Taybi syndrome caused by EP300 mutations , 2016, American journal of medical genetics. Part A.
[13] J. Moss,et al. A Comparative Study of Sociability in Angelman, Cornelia de Lange, Fragile X, Down and Rubinstein Taybi Syndromes and Autism Spectrum Disorder. , 2016, American journal on intellectual and developmental disabilities.
[14] G. Scarano,et al. Insights into genotype–phenotype correlations from CREBBP point mutation screening in a cohort of 46 Rubinstein–Taybi syndrome patients , 2015, Clinical genetics.
[15] A. Nordgren,et al. CREBBP and EP300 mutational spectrum and clinical presentations in a cohort of Swedish patients with Rubinstein–Taybi syndrome , 2015, Molecular genetics & genomic medicine.
[16] J. Moss,et al. Repetitive Behavior in Rubinstein–Taybi Syndrome: Parallels with Autism Spectrum Phenomenology , 2015, Journal of autism and developmental disorders.
[17] G. Scarano,et al. Clinical and molecular characterization of Rubinstein‐Taybi syndrome patients carrying distinct novel mutations of the EP300 gene , 2015, Clinical genetics.
[18] W. Goodman,et al. Obsessive-compulsive disorder. , 2014, The Psychiatric clinics of North America.
[19] L. Curfs,et al. Elimination disorders in persons with Prader–Willi and Fragile‐X syndromes , 2013, Neurourology and urodynamics.
[20] M. D. Graf,et al. Genetic testing insurance coverage trends: a review of publicly available policies from the largest US payers. , 2013, Personalized medicine.
[21] M. Keshavan,et al. A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome. , 2013, Research in developmental disabilities.
[22] R. Kosaki,et al. Age‐dependent change in behavioral feature in Rubinstein‐Taybi syndrome , 2012, Congenital anomalies.
[23] Donna B. Pincus,et al. Sleep-Related Problems in Children and Adolescents With Anxiety Disorders , 2011, Behavioral sleep medicine.
[24] C. Stevens,et al. Adults with Rubinstein–Taybi syndrome , 2011, American journal of medical genetics. Part A.
[25] S. Tuinier,et al. Psychiatric Profile in Rubinstein-Taybi Syndrome , 2009, Psychopathology.
[26] M. Bouvard,et al. Socio-Behavioral Characteristics of Children with Rubinstein-Taybi Syndrome , 2009, Journal of autism and developmental disorders.
[27] S. Whiteside,et al. Exploring the utility of the Spence Children's Anxiety Scales parent- and child-report forms in a North American sample. , 2008, Journal of anxiety disorders.
[28] J. Carr. Stability and change in cognitive ability over the life span: a comparison of populations with and without Down's syndrome. , 2005, Journal of intellectual disability research : JIDR.
[29] E. Seemanová,et al. DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein–Taybi syndrome (RSTS) and in another patient with incomplete RSTS , 2005, Human Genetics.
[30] J. Carey,et al. Rubinstein-Taybi syndrome: a natural history study. , 2005, American journal of medical genetics. Supplement.
[31] Olga V. Demler,et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.
[32] Johan T den Dunnen,et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. , 2005, American journal of human genetics.
[33] R. Rapee,et al. A parent-report measure of children's anxiety: psychometric properties and comparison with child-report in a clinic and normal sample. , 2004, Behaviour research and therapy.
[34] C. Stevens,et al. Rubinstein‐Taybi syndrome medical guidelines , 2003, American journal of medical genetics. Part A.
[35] C. Cruaud,et al. Molecular analysis of the CBP gene in 60 patients with Rubinstein-Taybi syndrome , 2002, Journal of medical genetics.
[36] G. Fisch,et al. Longitudinal Changes in Cognitive and Adaptive Behavior Scores in Children and Adolescents with the Fragile X Mutation or Autism , 2002, Journal of autism and developmental disorders.
[37] Avi Sadeh,et al. Sleep, neurobehavioral functioning, and behavior problems in school-age children. , 2002, Child development.
[38] C. Reid,et al. Rubinstein-Taybi syndrome and psychiatric disorders. , 2002, Journal of intellectual disability research : JIDR.
[39] T. Achenbach,et al. The Child Behavior Checklist and related forms for assessing behavioral/emotional problems and competencies. , 2000, Pediatrics in review.
[40] H. Boer,et al. Development and Behaviour in Genetic Syndromes: Rubinstein‐Taybi Syndrome , 1999 .
[41] M. Weissman. Cross-National Epidemiology of Obsessive-Compulsive Disorder , 1998, CNS Spectrums.
[42] B. Howard,et al. The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases , 1996, Cell.
[43] Raoul C. M. Hennekam,et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP , 1995, Nature.
[44] Y. Makita,et al. Submicroscopic deletion of chromosome region 16p13.3 in a Japanese patient with Rubinstein-Taybi syndrome. , 1994, American journal of medical genetics.
[45] K. Jackson,et al. Frequency of obsessive-compulsive disorder in a community sample of young adolescents. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.
[46] M. Weissman,et al. The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. , 1994, The Journal of clinical psychiatry.
[47] E. Mariman,et al. Rubinstein-Taybi syndrome caused by submicroscopic deletions within 16p13.3. , 1993, American journal of human genetics.
[48] W. Goodman,et al. Assessment of severity and change in obsessive compulsive disorder. , 1992, The Psychiatric clinics of North America.
[49] N. Tommerup,et al. Tentative assignment of a locus for Rubinstein-Taybi syndrome to 16p13.3 by a de novo reciprocal translocation, t(7;16)(q34;p13.3). , 1992, American journal of medical genetics.
[50] D. Lacombe,et al. Confirmation of assignment of a locus for Rubinstein-Taybi syndrome gene to 16p13.3. , 1992, American journal of medical genetics.
[51] Y. Kuroki,et al. Rubinstein-Taybi syndrome with de novo reciprocal translocation t(2;16)(p13.3;p13.3). , 1991, American journal of medical genetics.
[52] M. Aman,et al. Psychometric characteristics of the aberrant behavior checklist. , 1985, American journal of mental deficiency.
[53] J H RUBINSTEIN,et al. Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome. , 1963, American journal of diseases of children.
[54] A. Reiss,et al. The Influence of Hyperactivity, Impulsivity, and Attention Problems on Social Functioning in Adolescents and Young Adults With Fragile X Syndrome , 2019, Journal of attention disorders.
[55] J. Espada,et al. Spence Children’s Anxiety Scale--Parent Version; Spanish Translation , 2019, PsycTESTS Dataset.
[56] M. Aman,et al. Validity of the Aberrant Behavior Checklist in Children with Autism Spectrum Disorder , 2014, Journal of autism and developmental disorders.
[57] S. Havercamp,et al. Factor analysis and norms for parent ratings on the Aberrant Behavior Checklist-Community for young people in special education. , 2002, Research in developmental disabilities.
[58] W. Liemohn,et al. Behavioral characteristics of three children with the broad thumb-hallux (Rubinstein-Taybi) syndrome. , 1977, Biological psychiatry.
[59] C. Oancea,et al. [The Rubinstein-Taybi syndrome]. , 1971, Neurologia, psihiatria, neurochirurgia.